Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Deep Learning Multi-Modal Melanoma Detection: Algorithm Development and Validation
1
Zitationen
2
Autoren
2025
Jahr
Abstract
BACKGROUND: The visual similarity of melanoma and seborrheic keratosis has made it difficult for elderly patients with disabilities to know when to seek medical attention, contributing to the metastasis of melanoma. OBJECTIVE: In this paper, we present a novel multi-modal deep learning-based technique to distinguish between melanoma and seborrheic keratosis. METHODS: Our strategy is three-fold: (1) utilize patient image data to train and test three deep learning models using transfer learning (ResNet50, InceptionV3, and VGG16) and one author designed model, (2) use patient metadata to train and test a deep learning model, and (3) combine the predictions of the image model with the best accuracy and the metadata model, using nonlinear least squares regression to specify ideal weights to each model for a combined prediction. RESULTS: The accuracy of the combined model was 88% (195/221 classified correctly) on test data from the HAM10000 dataset. Model reliability was assessed by visualizing the output activation map of each model and comparing the diagnosis patterns to that of dermatologists. The addition of metadata to the image dataset was key to reducing the false negative and false positive rate simultaneously, thereby producing better metrics and improving overall model accuracy. CONCLUSIONS: Results from this experiment could be used to eliminate late diagnosis of melanoma via easy access to an app. Future experiments can utilize text data (subjective data pertaining to how the patient felt over a certain period of time) to allow this model to reflect the real hospital setting to a greater extent.
Ähnliche Arbeiten
Dermatologist-level classification of skin cancer with deep neural networks
2017 · 13.499 Zit.
Tumor Angiogenesis: Therapeutic Implications
1971 · 10.112 Zit.
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
2011 · 7.674 Zit.
Pembrolizumab versus Ipilimumab in Advanced Melanoma
2015 · 5.810 Zit.
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
2017 · 5.362 Zit.